Disclosure Panels Details Page
Hodgkin Lymphoma Panel - Disclosures as of 03/02/2018
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Ranjana Advani MD | Agensys, Inc. Bristol-Myers Squibb Company Celgene Corporation Cell Medica Fortyseven Genentech, Inc. Infinity Janssen Pharmaceutica Products, LP kura Merck & Co., Inc. Millennium Pharmaceuticals, Inc. Pharmacyclics Regeneron Pharmaceuticals, Inc. Seattle Genetics Teva Pharmaceuticals |
AstraZeneca Pharmaceuticals LP Bayer HealthCare Bristol-Myers Squibb Company Genentech, Inc. Gilead Juno Nanostring Pharmacyclics Seattle Genetics Sutro |
None | None | ✔ |
| Weiyun Ai MD, PhD | Bristol-Myers Squibb Company | Seattle Genetics | None | None | ✔ |
| Richard Ambinder MD, PhD | None | Case review 1 | Viracta | None | ✔ |
| Patricia Aoun MD, MPH | None | None | None | None | - |
| Philippe Armand MD, PhD | Adaptive Affimed Bristol-Myers Squibb Company GenMab Merck & Co., Inc. Pfizer Inc. Roche Laboratories, Inc. Tensha |
Private law firm | None | None | ✔ |
| Celeste Bello MD, MSPH | Seattle Genetics | None | Celgene Corporation Seattle Genetics |
None | ✔ |
| Cecil Benitez MD, PhD | None | None | None | None | - |
| Philip Bierman MD | None | None | None | None | - |
| Marian Birkeland PhD | None | None | None | None | - |
| Jennifer Burns BS | None | None | None | None | - |
| Robert Chen MD | Bristol-Myers Squibb Company Pharmacyclics Seattle Genetics |
Bristol-Myers Squibb Company Genentech, Inc. Merck & Co., Inc. Pfizer Inc. Seattle Genetics |
Genentech, Inc. Merck & Co., Inc. Seattle Genetics |
None | ✔ |
| Bouthaina Dabaja MD | None | None | None | None | - |
| Robert Dean MD | None | None | None | None | - |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Andres Forero-Torres MD | Abbott Laboratories Celgene Corporation Daiichi- Sankyo Co. Genentech, Inc. GlaxoSmithKline Incyte Novartis Pharmaceuticals Corporation Oncothyreon Pfizer Inc. Pharmacyclics Seattle Genetics Synta Pharmaceuticals Corp. TRACON YM BioScience Inc. |
Incyte Seattle Genetics |
None | None | ✔ |
| Leo Gordon MD | Janssen Pharmaceutica Products, LP | Takeda Pharmaceuticals North America, Inc. | None | None | ✔ |
| Kristina Gregory MSN, RN, OCN | None | None | None | None | - |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Francisco Hernandez-Ilizaliturri MD | None | Celgene Corporation Novartis Pharmaceuticals Corporation Seattle Genetics |
Pharmacyclics | None | ✔ |
| Ephraim Hochberg MD | None | Flatiron Intervention Insights |
None | None | - |
| Richard Hoppe MD | None | None | None | None | - |
| Jiayi Huang MD | Cantex Pharmaceuticals Pfizer Inc. |
None | None | None | ✔ |
| Patrick Johnston MD, PhD | None | None | None | None | - |
| Mark Kaminski MD | Millennium Pharmaceuticals, Inc. | Nordic Nanovector | None | None | ✔ |
| Ann Karosas RPh, BCOP | None | None | None | None | - |
| Vaishalee Kenkre MD | Abbott Laboratories Celgene Corporation MedImmune Inc. MEI Pharma Seattle Genetics |
None | None | None | ✔ |
| Nadia Khan MD | Bristol-Myers Squibb Company Fox Chase Cancer Center |
None | Genentech, Inc. | None | - |
| Kami Maddocks MD | Bristol-Myers Squibb Company Merck & Co., Inc. Novartis Pharmaceuticals Corporation Pharmacyclics |
Genentech, Inc. | None | None | ✔ |
| David Maloney MD, PhD | Celgene Corporation Juno Therapeutics |
Celgene Corporation Gilead Kite Pharma |
None | None | ✔ |
| Joan McClure MS | None | None | None | None | - |
| Monika Metzger MD | Seattle Genetics | None | None | None | ✔ |
| Joseph Moore MD | None | None | None | None | ✔ |
| David Morgan MD | None | None | None | None | ✔ |
| Craig Moskowitz MD | Merck & Co., Inc. Pharmacyclics seattle genetics |
Celgene Corporation Genentech, Inc. Merck & Co., Inc. Seattle Genetics |
Seattle Genetics | None | ✔ |
| Carolyn Mulroney MD | Amgen Inc. Incyte Kiadis Pharma Merck & Co., Inc. Nordic nano vector Takeda Pharmaceuticals North America, Inc. TG therapeutics |
None | None | None | ✔ |
| Ndiya Ogba PhD | None | None | None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Rachel Rabinovitch MD | NRG Quality Committee | None | None | None | - |
| Stuart Seropian MD | None | None | None | None | ✔ |
| Jack Skinner PhD | None | None | None | None | - |
| Randa Tao MD | None | None | None | None | ✔ |
| Amy Tuten PharmD, BCOP | None | None | None | None | - |
| Jane Winter MD | GlaxoSmithKline Merck & Co., Inc. Seattle Genetics |
Celgene Corporation Novartis Pharmaceuticals Corporation Pfizer Inc. |
None | None | ✔ |
| Joachim Yahalom MD | None | None | None | None | ✔ |